Related Experiment Video
Updated: May 2, 2026

Optimizing the Modified No-Scalpel Vasectomy Technique
Published on: October 18, 2024
The safety, efficacy and acceptability of task sharing tubal sterilization to midlevel providers: a systematic review
Maria Isabel Rodriguez1, Cristin Gordon-Maclean2
1Oregon Health & Science University Department of Obstetrics & Gynecology.
Background:
Task sharing is an important strategy for increasing access to modern, effective contraception for women and reducing unmet need for family planning.
Objective:
The objective was to identify evidence for the safety, efficacy or acceptability of task sharing tubal sterilization to midlevel providers.
Search Strategy:
We searched PubMed, Cochrane and Popline for articles in all languages using the following key words: task sharing, tubal sterilization, midlevel providers, task shifting.
Selection Criteria:
All studies reporting on any measure of safety, efficacy or acceptability of tubal sterilization performed by any cadre of midlevel providers.
Data Collection And Analysis:
Data were independently abstracted by two authors and graded using the United States Preventive Services Task Force rating for evidence quality. Heterogeneity of outcome measures precluded a meta-analysis.
Main Results:
Nine studies of fair to poor quality reported on safety and acceptability outcomes. Generalizability of findings is limited by inadequate sample size and lack of statistical comparisons. No study reported on long-term efficacy outcomes.
Conclusions:
Well-designed clinical trials, of adequate sample size, are urgently needed to establish the safety, efficacy and acceptability of task sharing tubal sterilization to midlevel providers.
More Related Videos
09:51Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
Published on: March 21, 2018
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025